Institution · Johnson & Johnson (United States)
Most cited papers from Johnson & Johnson (United States)
What are the most cited papers from Johnson & Johnson (United States)?
The most cited paper from Johnson & Johnson (United States) is "Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation" (Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al., 2011), with 9,484 citations. Next come "Biological insights from 108 schizophrenia-associated genetic loci" (8,181) and "SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials" (8,142).
Showing 50 of 58 papers. Every paper with more than 1,399 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine | 10 Aug 2011 | 9,484 |
| 2 | Biological insights from 108 schizophrenia-associated genetic loci Stephan Ripke et al. · Nature | Jul 2014 | 8,181 |
| 3 | SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials An‐Wen Chan, Jennifer Tetzlaff, Douglas G. Altman et al. · Annals of Internal Medicine | 5 Feb 2013 | 8,142 |
| 4 | Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Bruce Charles Neal, Vlado Perkovic, Kenneth W. Mahaffey et al. · New England Journal of Medicine | 12 Jun 2017 | 7,908 |
| 5 | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials A.-W. Chan, Jennifer Tetzlaff, Peter Christian Gøtzsche et al. · BMJ | 9 Jan 2013 | 7,135 |
| 6 | Bariatric Surgery Hēnry Buchwald, Yoav Avidor, Eugene Braunwald et al. · JAMA | 12 Oct 2004 | 6,822 |
| 7 | Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Vlado Perkovic et al. · New England Journal of Medicine | 14 Apr 2019 | 6,216 |
| 8 | The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research Nathalie Percie du Sert et al. · PLoS Biology | 14 Jul 2020 | 6,005 |
| 9 | Natural products in drug discovery: advances and opportunities Atanas G. Atanasov et al. · Nature Reviews Drug Discovery | 28 Jan 2021 | 5,395 |
| 10 | Conceptual Density Functional Theory Paul Geerlings, Frank De Proft, Wilfried Langenaeker · Chemical Reviews | 17 Apr 2003 | 5,304 |
| 11 | Anomalies: The Endowment Effect, Loss Aversion, and Status Quo Bias Daniel J. Kahneman, Jack L. Knetsch, Richard H. Thaler · The Journal of Economic Perspectives | Feb 1991 | 5,077 |
| 12 | FinnGen provides genetic insights from a well-phenotyped isolated population Mitja Kurki et al. · Nature | 18 Jan 2023 | 4,362 |
| 13 | A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization Marie‐Claude Morice, Patrick W.J.C. Serruys, José Eduardo Sousa et al. · New England Journal of Medicine | 6 Jun 2002 | 4,047 |
| 14 | Core outcome measures for chronic pain clinical trials: IMMPACT recommendations Robert H. Dworkin et al. · Pain | 6 Nov 2004 | 3,789 |
| 15 | Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations Robert H. Dworkin et al. · Journal of Pain | 13 Dec 2007 | 3,496 |
| 16 | Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression eQTLGen et al. · Nature Genetics | 26 Apr 2018 | 3,347 |
| 17 | Mapping genomic loci implicates genes and synaptic biology in schizophrenia Vassily Vladimirovich Trubetskoy et al. · Nature | 8 Apr 2022 | 2,894 |
| 18 | Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0 Nathalie Percie du Sert et al. · PLoS Biology | 14 Jul 2020 | 2,875 |
| 19 | Where do you know what you know? The representation of semantic knowledge in the human brain Karalyn E. Patterson, Peter J. Nestor, Timothy T. Rogers · Nature reviews. Neuroscience | 20 Nov 2007 | 2,828 |
| 20 | Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy Charles J. Ryan et al. · New England Journal of Medicine | 10 Dec 2012 | 2,827 |
| 21 | Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription Peter Lloyd Jones, Gert Jan C. Veenstra, Paul A. Wade et al. · Nature Genetics | Jun 1998 | 2,746 |
| 22 | Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Yixin Wang, Jan G.M. Klijn, Yi Zhang et al. · The Lancet | Feb 2005 | 2,723 |
| 23 | Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 JERALD C. SADOFF et al. · New England Journal of Medicine | 21 Apr 2021 | 2,625 |
| 24 | New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics | Apr 2022 | 2,608 |
| 25 | Carbapenemases: the Versatile β-Lactamases Anne Marie Queenan, Karen Bush · Clinical Microbiology Reviews | Jul 2007 | 2,516 |
| 26 | TheHerschel-SPIRE instrument and its in-flight performance Matthew J. Griffin et al. · Astronomy and Astrophysics | Jul 2010 | 2,276 |
| 27 | The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Eric H. Karran, Marc H. Mercken, Bart De Strooper · Nature Reviews Drug Discovery | 19 Aug 2011 | 2,240 |
| 28 | A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science | 9 Dec 2004 | 2,187 |
| 29 | Analysis of shared heritability in common disorders of the brain Verneri Anttila et al. · Science | 21 Jun 2018 | 2,056 |
| 30 | Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals Harry M. Olson, Graham R. Betton, Denise E. Robinson et al. · Regulatory Toxicology and Pharmacology | Aug 2000 | 2,056 |
| 31 | Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease Stephen Salloway et al. · New England Journal of Medicine | 22 Jan 2014 | 1,999 |
| 32 | The Prevention and Treatment of Missing Data in Clinical Trials Roderick J. A. Little, Ralph B. D’Agostino, Michael L. Cohen et al. · New England Journal of Medicine | 3 Oct 2012 | 1,932 |
| 33 | Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma Jesús F. San Miguel et al. · New England Journal of Medicine | 27 Aug 2008 | 1,913 |
| 34 | Rivaroxaban in Patients with a Recent Acute Coronary Syndrome Jessica L. Mega, Eugene Braunwald, Stephen D. Wiviott et al. · New England Journal of Medicine | 13 Nov 2011 | 1,902 |
| 35 | Cyclodextrins as pharmaceutical solubilizers Marcus Eli Brewster, Þorsteinn Loftsson · Advanced Drug Delivery Reviews | 30 May 2007 | 1,879 |
| 36 | Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease Brian G. Feagan et al. · New England Journal of Medicine | 16 Nov 2016 | 1,860 |
| 37 | Glucagon-like peptide 1 (GLP-1) Timo D. Müller et al. · Molecular Metabolism | 30 Sep 2019 | 1,836 |
| 38 | Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore Fraser F. Fleming, Lihua Yao, Ponneri Chandrababu Ravikumar et al. · Journal of Medicinal Chemistry | 30 Aug 2010 | 1,756 |
| 39 | Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study Jesús G. Berdeja et al. · The Lancet | 24 Jun 2021 | 1,751 |
| 40 | Drug assay using antibody mimics made by molecular imprinting George Vlatakis, Lars I. Andersson, Ralf R. Müller et al. · Nature | Feb 1993 | 1,751 |
| 41 | The rhizosphere: a playground and battlefield for soilborne pathogens and beneficial microorganisms Jos M. Raaijmakers, Timothy C. Paulitz, Christian Steinberg et al. · Plant and Soil | 22 Feb 2008 | 1,730 |
| 42 | Plasma proteomic associations with genetics and health in the UK Biobank Benjamin B. Sun et al. · Nature | 4 Oct 2023 | 1,716 |
| 43 | Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia Willemijn J. Jansen et al. · JAMA | 19 May 2015 | 1,662 |
| 44 | The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients Maria Rosa Costanzo et al. · The Journal of Heart and Lung Transplantation | 20 Jul 2010 | 1,662 |
| 45 | 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association Steven Mark Greenberg, Wendy Ziai, Charlotte Cordonnier et al. · Stroke | 17 May 2022 | 1,655 |
| 46 | Genome-wide association study identifies 30 loci associated with bipolar disorder Eli A. Stahl et al. · Nature Genetics | May 2019 | 1,654 |
| 47 | Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells Alireza Rezania, Jennifer E. Bruin, Payal Arora et al. · Nature Biotechnology | 11 Sep 2014 | 1,647 |
| 48 | Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology Niamh Mullins et al. · Nature Genetics | 17 May 2021 | 1,635 |
| 49 | A scalable SCENIC workflow for single-cell gene regulatory network analysis Bram Van de Sande, Christopher Flerin, Kristofer Davie et al. · Nature Protocols | 19 Jun 2020 | 1,635 |
| 50 | Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI Charles Michael Gibson, Roxana Mehran, Christoph Bode et al. · New England Journal of Medicine | 14 Nov 2016 | 1,595 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.